Sectors
DCOY
Decoy Therapeutics Inc.
3.05
2 x 2.16
2 x 3.85
bid
ask
+
0.15
5.17%
2 @ 07:30 PM
3.18 +0.13 (4.26%)
| Ytd | -60.85% | |
| 1y | -95.59% |
2.96
day range
3.07
2.85
52 week range
70.80
| Open | 3.01 | Prev Close | 2.90 | Low | 2.96 | High | 3.07 | Mkt Cap | 2.00M |
| Vol | 12.45K | Avg Vol | 250.20K | EPS | 115.98 | P/E | 0.03 | Forward P/E | N/A |
| Beta | 0.64 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 4.91 | 200-d Avg | 7.23 | 1yr Est | 0.00 |
| Income Statement | |||
| Total Revenue | 227.63K | ||
| Revenues (USD) | 227.63K | ||
| Gross Profit | 227.63K | ||
| Operating Expenses | 2.63M | ||
| Research and Development Expense | 1.30M | ||
| Selling, General and Administrative Expense | 1.33M | ||
| Operating Income | -2.40M | ||
| Net Income | -2.37M | ||
| Net Income Common Stock | -2.37M | ||
| Net Income Common Stock (USD) | -2.37M | ||
| Consolidated Income | -2.37M | ||
| Earnings per Basic Share | -4.46 | ||
| Earnings per Basic Share (USD) | -4.46 | ||
| Earnings per Diluted Share | -4.46 | ||
| Earning Before Interest & Taxes (EBIT) | -2.37M | ||
| Earning Before Interest & Taxes (USD) | -2.37M | ||
| Weighted Average Shares | 531.97K | ||
| Weighted Average Shares Diluted | 531.97K | ||
| Balance Sheet | |||
| Cash and Equivalents | 8.29M | ||
| Cash and Equivalents (USD) | 8.29M | ||
| Current Assets | 8.57M | ||
| Property, Plant & Equipment Net | 399.08K | ||
| Total Assets | 9.00M | ||
| Current Liabilities | 4.68M | ||
| Total Liabilities | 4.68M | ||
| Accumulated Retained Earnings (Deficit) | -99.04M | ||
| Shareholders Equity | 4.32M | ||
| Shareholders Equity (USD) | 4.32M | ||
| Assets Non-Current | 427.85K | ||
| Deferred Revenue | 3.00M | ||
| Trade and Non-Trade Payables | 1.47M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 13.63K | ||
| Net Cash Flow from Financing | 3.16M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 468.50K | ||
| Issuance (Purchase) of Equity Shares | 3.16M | ||
| Net Cash Flow from Operations | -2.65M | ||
| Share Based Compensation | 206.18K | ||